S&P 500 index data: S&P 500 Copyright ©
|Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients|
|CytoSorbents Announces Closing of Public Offering|
|CytoSorbents Submits IDE Application to FDA for U.S. CytoSorb® Cardiac Surgery Trial|
|CytoSorbents To Present at OneMedForum 2015 and Exhibit at the 44th Society of Critical Care Medicine Congress (2015/1/7)|
Click above to view more mutual fund data and stats for ctso - Cytosorbents Corp.